DIVI'S LABORATORIES LTD. - 532488 - Outcome Of Board Meeting - Unaudited Financial Results For The Quarter And Half Year Ended 30 September, 2020
As enclosed.07-11-2020
DIVI'S LABORATORIES LTD. - 532488 - Schedule Of Earnings Conference Call Q2 FY21
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the schedule of Earnings conference call to be held on 07 November, 2020. This is for your information and records.30-10-2020
DIVI'S LABORATORIES LTD. - 532488 - Board Meeting Intimation for Inter-Alia, Considering And Approving The Unaudited Financial Results For The Quarter And Half Year Ended 30 September, 2020
DIVI''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2020 ,inter alia, to consider and approve the standalone and consolidated unaudited financial results for the quarter and half year ended 30 September, 2020.27-10-2020
Divis Laboratories Ltd - 532488 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
We have earlier informed vide our letter dated 02 July, 2020 that SEBI has passed an Impounding Order cum Show Cause notice bearing no. WTM/GM/IVD/14/2020-21 dated 01 July, 2020 against Mr. L. Kishore Babu, Chief Financial Officer of the Company and others (Noticees). The Noticees filed settlement application(s) before SEBI under the SEBI (Settlement Proceedings) Regulations, 2018 in respect of the said proceedings, to settle without admitting or denying the findings of fact and conclusions of law. SEBI, on the Noticees complying with the terms of the proposal for settlement, has passed a Settlement Order vide ref. no. SO/EFD-2/SD /356/OCTOBER/2020 dated 21 October, 2020 settling the enforcement proceedings against Noticees. This is for your information and records.23-10-2020
DIVI'S LABORATORIES LTD. - 532488 - Compliance Certificate For Half Year Ended 30 September, 2020
Please find enclosed Compliance Certificate as required under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended 30 September, 2020.19-10-2020
DIVI'S LABORATORIES LTD. - 532488 - Shareholding for the Period Ended September 30, 2020
Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here19-10-2020
DIVI'S LABORATORIES LTD. - 532488 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we herewith submit certificate from KFin Technologies Private Limited (formerly known as Karvy Fintech Private Limited), Registrar & Share Transfer Agent of the Company dated 12 October, 2020 for the quarter ended 30 September, 2020.13-10-2020
DIVI'S LABORATORIES LTD. - 532488 - Compliance Certificate For Half Year Ended 30 September, 2020
Pursuant to Regulation7(3) of the SEBI (LODR) Regulations, 2015, we enclose herewith Compliance Certificate from the Company and the Registrar and Share Transfer Agent for half year ended 30 September, 2020.13-10-2020
DIVI'S LABORATORIES LTD. - 532488 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0550 Name of the Signatory :- M Satish ChoudhuryDesignation :- Company Secretary and Compliance Officer13-10-2020
DIVI'S LABORATORIES LTD. - 532488 - Closure of Trading Window
Pursuant to the Company's Code of Conduct for Prevention of Insider Trading (the Code), we hereby inform that the Trading Window for dealing in securities of the Company will remain closed for Designated Persons and their Immediate Relatives, as well as Insiders covered under the Code, from 01 October, 2020 till 48 hours after the declaration of Unaudited Financial Results for the second quarter and half year ended 30 September, 2020. The date of Board Meeting for declaration of the financial results of the Company for the second quarter and half year ended 30 September, 2020 will be intimated in due course. This is for your information and records.30-09-2020